Gabalex Capital Management LLC Johnson & Johnson Transaction History

Gabalex Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$155.93 - $173.01 $4.68 Million - $5.19 Million	-30,000 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$159.48 - $171.07 $4.78 Million - $5.13 Million	-30,000 Reduced 50.0%	30,000 $4.94 Million
Q1 2021 May 12, 2021	BUY	$153.07 - $170.48 $1.99 Million - $2.21 Million	12,973 Added 27.59%	60,000 $9.86 Million
Q4 2020 Feb 03, 2021	SELL	$137.11 - $157.38 $7.26 Million - $8.34 Million	-52,973 Reduced 52.97%	47,027 $7.4 Million
Q3 2020 Nov 03, 2020	BUY	$140.38 - $153.83 $701,900 - $769,150	5,000 Added 5.26%	100,000 $14.9 Million
Q2 2020 Aug 04, 2020	BUY	$128.81 - $155.51 $12.2 Million - $14.8 Million	95,000 New	95,000 $13.4 Million

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Gabalex Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gabalex Capital Management LLC with notifications on news.